related documents For How Long Should the Treatment with Vitamin K Antagonists Be Maintained? Conferences New antithrombotic drugs: Beyond aspirin and heparin - Chairman's summary Conferences Optimization of treatment for venous thromboembolism and prevention of recurrences - Co-chairman's summary Conferences